Crohn's Disease and Colitis Trial, By Invitation NCT07721441 Sponsor: Tang-Du Hospital Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, By Invitation

NCT07721441
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are 18 years of age or older
  • People with ulcerative colitis (a type of inflammatory bowel disease) who are starting their first biologic treatment (a type of medication made from living cells)
  • People who have had a confirmed diagnosis of ulcerative colitis for more than 3 months
  • People whose ulcerative colitis is considered moderately to severely active
  • People whose ulcerative colitis affects a moderate or large portion of the large bowel (classified as E2 or E3 by a doctor)
  • People who are willing to sign a consent form agreeing to take part in the study

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are under 18 years of age
  • People who have previously received biologic therapy for their condition
  • People whose ulcerative colitis affects only a very small portion of the bowel (classified as E1 by a doctor)
  • Women who are pregnant or currently breastfeeding
  • People who have medical reasons that make biologic medications unsuitable for them (confirm with trial site)
  • People a doctor considers unsuitable for this study based on their overall clinical situation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Tang-Du Hospital
Registry
ClinicalTrials.gov
Start date
18 June 2026
Est. completion
30 June 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Cut-off value and predictive efficacy of the early decline in fecal calprotectin for mucosal healing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov